- Home
- ETON vs FBIZ Comparison
ETON vs FBIZ Comparison
Compare ETON & FBIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- FBIZ
- Stock Information
- Founded
- ETON 2017
- FBIZ 1909
- Country
- ETON United States
- FBIZ United States
- Employees
- ETON N/A
- FBIZ N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- FBIZ Major Banks
- Sector
- ETON Health Care
- FBIZ Finance
- Exchange
- ETON Nasdaq
- FBIZ Nasdaq
- Market Cap
- ETON 388.3M
- FBIZ 446.6M
- IPO Year
- ETON 2018
- FBIZ N/A
- Fundamental
- Price
- ETON $14.39
- FBIZ $46.96
- Analyst Decision
- ETON Strong Buy
- FBIZ Strong Buy
- Analyst Count
- ETON 3
- FBIZ 4
- Target Price
- ETON $29.67
- FBIZ $56.50
- AVG Volume (30 Days)
- ETON 420.1K
- FBIZ 44.3K
- Earning Date
- ETON 08-07-2025
- FBIZ 07-24-2025
- Dividend Yield
- ETON N/A
- FBIZ 2.48%
- EPS Growth
- ETON N/A
- FBIZ 22.50
- EPS
- ETON N/A
- FBIZ 5.60
- Revenue
- ETON $48,327,000.00
- FBIZ $150,952,000.00
- Revenue This Year
- ETON $101.12
- FBIZ $17.98
- Revenue Next Year
- ETON $45.71
- FBIZ $8.26
- P/E Ratio
- ETON N/A
- FBIZ $8.36
- Revenue Growth
- ETON 40.88
- FBIZ 8.24
- 52 Week Low
- ETON $3.25
- FBIZ $39.65
- 52 Week High
- ETON $21.48
- FBIZ $56.46
- Technical
- Relative Strength Index (RSI)
- ETON 45.76
- FBIZ 31.34
- Support Level
- ETON $13.78
- FBIZ $45.90
- Resistance Level
- ETON $15.73
- FBIZ $54.49
- Average True Range (ATR)
- ETON 0.75
- FBIZ 1.44
- MACD
- ETON -0.01
- FBIZ -0.81
- Stochastic Oscillator
- ETON 31.98
- FBIZ 11.94
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About FBIZ First Business Financial Services Inc.
First Business Financial Services Inc operates as a bank holding company. The Bank operates as a business bank, delivering a full line of commercial banking products including commercial loans and commercial real estate loans, to meet the specific needs of small and medium-sized businesses, business owners, executives, professionals, and high-net-worth individuals. The company's products and services include commercial lending, SBA lending and servicing, asset-based lending, equipment financing, factoring, trust, and investment services, treasury management services, and a broad range of deposit products. Geographically all the business activity functioned through the region of the United States.